安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- REVLIMID® (lenalidomide) - Official Patient Website
REVLIMID should not be used to treat people who have chronic lymphocytic leukemia (CLL) unless they are participants in a controlled clinical trial It is not known if REVLIMID is safe and effective in children
- Revlimid: Uses, Dosage, Side Effects - Drugs. com
Revlimid is a medication used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma, marginal zone lymphoma, and anemia in myelodysplastic syndromes (MDS) in adults
- Lenalidomide (Revlimid): Uses, Side Effects, Interactions . . . - WebMD
Find patient medical information for Lenalidomide (Revlimid) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Lenalidomide (oral route) - Side effects dosage - Mayo Clinic
Description Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS) Patients with MDS may have very low red blood cell counts and require blood transfusions Lenalidomide is also used in combination with dexamethasone to treat multiple myeloma (plasma cell cancer) It is also used as maintenance treatment in patients with
- REVLIMID U. S. Prescribing Information - BMS
REVLIMID has demonstrated a significantly increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as risk of myocardial infarction and stroke in patients with multiple myeloma who were treated with REVLIMID and dexamethasone therapy
- Revlimid (Lenalidomide): Side Effects, Uses, Dosage . . . - RxList
REVLIMID has demonstrated a significantly increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as risk of myocardial infarction and stroke in patients with multiple myeloma who were treated with REVLIMID and dexamethasone therapy
- Revlimid (lenalidomide) - International Myeloma Foundation
Explore Revlimid® (lenalidomide), an oral medication for multiple myeloma management Understand its side effects and available clinical trials Learn more here
- Multiple Myeloma Treatment Option | REVLIMID® (lenalidomide)
REVLIMID is not indicated and is not recommended for the treatment of patients with chronic lymphocytic leukemia (CLL) outside of controlled clinical trials REVLIMID is only available through a restricted distribution program, Lenalidomide REMS
|
|
|